| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |